Clin Dermatol. 2025 May 15:S0738-081X(25)00147-6. doi: 10.1016/j.clindermatol.2025.05.005. Online ahead of print.
ABSTRACT
Hidradenitis suppurativa in children and adolescents share similar clinical features and distribution of lesions as in adult patients, causing significant physical and psychologic burdens. The disease is associated with several comorbidities; therefore, a diagnostic work-up should include screening for metabolic, psychiatric, autoimmune, and hyperandrogenic comorbidities. The goal of the treatment is to alleviate pain, minimize inflammation and scarring, and prevent disease progression. Currently, there are no hidradenitis suppurativa treatment guidelines for children and adolescents, and the treatment primarily relies on the management of hidradenitis suppurativa in adults. We summarize the current information about the epidemiology, pathogenesis, clinical features, comorbidities, diagnostic work-up, and treatment options for children and adolescents afflicted with hidradenitis suppurativa.
PMID:40381967 | DOI:10.1016/j.clindermatol.2025.05.005
AI-Assisted Evidence Search
Share Evidence Blueprint
Search Google Scholar